Total Payments
$529.34
2023 Payments
$133.90
Companies
7
Transactions
21
Medicare Patients
1,386
Medicare Billing
$212,350
Payment Breakdown by Category
Food & Beverage$529.34 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $529.34 | 21 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $154.93 | 12 | $0 (2020) |
| Neurocrine Biosciences, Inc. | $133.90 | 1 | $0 (2023) |
| AbbVie, Inc. | $113.96 | 1 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $39.12 | 2 | $0 (2020) |
| Mylan Specialty L.P. | $35.83 | 2 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $34.39 | 2 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $17.21 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $133.90 | 1 | Neurocrine Biosciences, Inc. ($133.90) |
| 2022 | $39.18 | 2 | E.R. Squibb & Sons, L.L.C. ($21.97) |
| 2020 | $29.91 | 2 | PFIZER INC. ($15.43) |
| 2019 | $273.86 | 12 | AbbVie, Inc. ($113.96) |
| 2018 | $52.49 | 4 | PFIZER INC. ($52.49) |
All Payment Transactions
21 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/07/2023 | Neurocrine Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $133.90 | General |
| 12/14/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $21.97 | General |
| Category: Cardiovascular | ||||||
| 07/14/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/03/2020 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/28/2020 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/29/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $12.44 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/30/2019 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: Respiratory and Allergy | ||||||
| 08/28/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $11.84 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/22/2019 | AbbVie, Inc. | Mavyret (Drug) | Food and Beverage | In-kind items and services | $113.96 | General |
| Category: Virology | ||||||
| 08/22/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.42 | General |
| Category: Cardiovascular | ||||||
| 08/13/2019 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Respiratory and Allergy | ||||||
| 08/06/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $12.17 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/29/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/14/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $11.91 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 04/18/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 03/27/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 01/29/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $12.11 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 09/11/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 08/23/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $12.27 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 04/16/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 03/13/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 383 | 773 | $494,958 | $62,579 |
| 2022 | 4 | 356 | 813 | $567,325 | $62,837 |
| 2021 | 6 | 338 | 476 | $389,237 | $43,836 |
| 2020 | 8 | 309 | 493 | $378,260 | $43,098 |
Total Patients
1,386
Total Services
2,555
Medicare Billing
$212,350
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 162 | 407 | $292,226 | $37,494 | 12.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 97 | 239 | $119,500 | $14,584 | 12.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 94 | 95 | $70,015 | $8,332 | 11.9% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 11 | 13 | $4,355 | $1,091 | 25.0% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2023 | 19 | 19 | $8,862 | $1,079 | 12.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 191 | 555 | $398,490 | $44,259 | 11.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 107 | 107 | $78,859 | $8,640 | 11.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 46 | 137 | $68,500 | $7,538 | 11.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 12 | 14 | $21,476 | $2,400 | 11.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 85 | 165 | $122,282 | $13,646 | 11.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 70 | 70 | $100,765 | $11,366 | 11.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 64 | 121 | $62,011 | $7,103 | 11.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 69 | 70 | $53,460 | $6,166 | 11.5% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 31 | 31 | $40,886 | $4,445 | 10.9% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 19 | 19 | $9,833 | $1,111 | 11.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 96 | 244 | $180,828 | $20,618 | 11.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 70 | 72 | $54,987 | $6,259 | 11.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 25 | 25 | $35,988 | $4,099 | 11.4% |
| 99226 | Subsequent observation care, typically 35 minutes per day | Facility | 2020 | 24 | 41 | $30,591 | $3,476 | 11.4% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2020 | 22 | 22 | $29,016 | $3,297 | 11.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 23 | 40 | $20,500 | $2,345 | 11.4% |
| 99217 | Hospital observation care on day of discharge | Facility | 2020 | 27 | 27 | $13,973 | $1,592 | 11.4% |
| 99497 | Advance care planning by the physician or other qualified health care professional | Facility | 2020 | 22 | 22 | $12,377 | $1,411 | 11.4% |
About Dr. Priyanka Attri, DO
Dr. Priyanka Attri, DO is a Hospitalist healthcare provider based in Mt Vernon, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/26/2015. The National Provider Identifier (NPI) number assigned to this provider is 1023490059.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Priyanka Attri, DO has received a total of $529.34 in payments from pharmaceutical and medical device companies, with $133.90 received in 2023. These payments were reported across 21 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($529.34).
As a Medicare-enrolled provider, Attri has provided services to 1,386 Medicare beneficiaries, totaling 2,555 services with total Medicare billing of $212,350. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Hospitalist
- Other Specialties Internal Medicine
- Location Mt Vernon, WA
- Active Since 06/26/2015
- Last Updated 09/16/2021
- Taxonomy Code 208M00000X
- Entity Type Individual
- NPI Number 1023490059
Products in Payments
- Mavyret (Drug) $113.96
- CHANTIX (Drug) $103.05
- ELIQUIS (Drug) $86.27
- ENTRESTO (Drug) $39.12
- Yupelri (Drug) $35.83
- XARELTO (Drug) $17.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.